Columbus Venture Partners logo

Columbus Venture Partners

Europe, Madrid, Spain, Madrid

Description

Columbus Venture Partners is an independent venture capital that invests in early-stage opportunities in the life science industry.

Investor Profile

Columbus Venture Partners has made 16 investments, with 3 in the past 12 months and 63% as lead.

Stage Focus

  • Series Unknown (38%)
  • Series A (19%)
  • Series C (13%)
  • Series B (13%)
  • Convertible Note (6%)
  • Series D (6%)
  • Seed (6%)

Country Focus

  • Spain (44%)
  • United States (25%)
  • United Kingdom (13%)
  • France (6%)
  • Israel (6%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Pharmaceutical
  • Therapeutics
  • Alternative Protein
  • Food Processing
  • Nutrition
  • Machine Learning
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Columbus Venture Partners frequently co-invest with?

Sangha Capital
Europe, Geneve, Switzerland, Genève
Co-Investments: 2
CV
North America, Massachusetts, United States, Boston
Co-Investments: 2
Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 5
Advent Life Sciences
Europe, England, United Kingdom, London
Co-Investments: 7
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 3
CC
Europe, Madrid, Spain, Madrid
Co-Investments: 2
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 2
North South Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Sound Bioventures
Europe, Skane Lan, Sweden, Malmö
Co-Investments: 3
Co-Investments: 3

Which angels does Columbus Venture Partners often collaborate with?

BT
North America, Massachusetts, United States, Marblehead
Shared Deals: 2

What are some of recent deals done by Columbus Venture Partners?

Lutris Pharma

Tel Aviv-yafo, Tel Aviv, Israel

Lutris Pharma develops drugs to improve anti-cancer therapy effectiveness.

BiotechnologyFirst AidHealth CareWellness
Series UnknownJan 28, 2025
Amount Raised: $30,000,000

Tolerance Bio is a biopharmaceutical company focused on manipulating immune tolerance via the thymus.

Biotechnology
SeedOct 15, 2024
Amount Raised: $20,200,000
Artax Biopharma

Cambridge, Massachusetts, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Convertible NoteAug 6, 2024
Amount Raised: $8,000,000
Multiverse Computing

Donostia-san Sebastián, Pais Vasco, Spain

Multiverse Computing is a quantum software company that applies advanced solutions to solve complex challenges.

Machine LearningQuantum ComputingSoftware
Series AMar 5, 2024
Amount Raised: $27,139,723
Curve Therapeutics

Southampton, Southampton, United Kingdom

Curve develops an innovative screening platform.

Biotechnology
Series AFeb 27, 2024
Amount Raised: $51,355,077
Cocoon Bioscience

Madrid, Madrid, Spain

Cocoon Bioscience produces recombinant proteins and enzymes for individual protein, nutrition, and healthcare applications.

Alternative ProteinBiotechnologyFood ProcessingNutrition
Series UnknownNov 3, 2023
Amount Raised: $2,147,190
ARTHEx Biotech

Valencia, Comunidad Valenciana, Spain

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Biotechnology
Series BMay 3, 2023
Amount Raised: $46,487,689
Cocoon Bioscience

Madrid, Madrid, Spain

Cocoon Bioscience produces recombinant proteins and enzymes for individual protein, nutrition, and healthcare applications.

Alternative ProteinBiotechnologyFood ProcessingNutrition
Series UnknownMar 14, 2023
Amount Raised: $16,090,053
Minoryx Therapeutics

Barcelona, Catalonia, Spain

Minoryx Therapeutics offers pharmacological chaperones, which are small molecule drugs used for the treatment of genetic diseases.

BiotechnologyGeneticsHealth CareMedicalPharmaceutical
Series CMay 31, 2022
Amount Raised: $54,744,055
Artax Biopharma

Cambridge, Massachusetts, United States

Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.

BiopharmaBiotechnologyHealth CareTherapeutics
Series UnknownMay 11, 2022
Amount Raised: $26,000,000